While symptoms are similar to Lyme, common tests for Lyme do not detect miyamotoi. http://www.nejm.org/doi/full/10.1056/NEJMc1215469 This study language is more honest:
The identification of B. miyamotoi antibody in 18 of our study patients, including seroconversion associated with symptoms in 3 patients, suggests that B. miyamotoi infection may be prevalent in areas where Lyme disease is endemic in the United States.